Evidence map›Paper›PMID 41296209›Full record

ArticleJournal of the Association for Research in Otolaryngology : JARO2025

On the Sharpness of Auditory Filters: Considering Subclinical Deficits Reveals Sharper Otoacoustic Emission Estimates of Frequency Selectivity in Humans.

Sajana Aryal, Srikanta K Mishra

Abstract read
In one paragraph

Article in Journal of the Association for Research in Otolaryngology : JARO, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sajana AryalDepartment of Speech, Language, and Hearing Sciences, University of Texas at Austin, Austin, TX, USA.
Srikanta K MishraDepartment of Speech, Language, and Hearing Sciences, University of Texas at Austin, Austin, TX, USA. srikanta.mishra@austin.utexas.edu.ORCID http://orcid.org/0000-0003-2519-6487

Funding

NIH/NIDCD 1 R01DC018046
6 · The paper itself

Abstract

purposeFrequency selectivity plays a crucial role in auditory perception, yet its precise characterization in humans remains debated. Most behavioral or physiologic estimates of frequency selectivity in humans have historically been obtained from individuals with clinically normal audiograms. However, emerging evidence suggests that even within this population, subclinical cochlear deficits may be prevalent, potentially skewing prior tuning estimates toward broader bandwidths. Here, we tested the hypothesis that human cochlear tuning is sharper when subclinical deficits, specifically hearing sensitivity above 8000 Hz, are considered.

methodsUsing stimulus frequency otoacoustic emission (SFOAE) delays, we obtained physiological estimates of cochlear tuning sharpness (Q

resultsOur findings demonstrate that controlling for subclinical deficits results in significantly sharper (higher) tuning estimates at 2000 and 2828 Hz among the tested frequencies. Additionally, applying a normative criterion for extended high-frequency hearing, we observed narrower equivalent rectangular bandwidths-approximately two times sharper-in individuals with better extended high-frequency sensitivity. The Q

conclusionThese findings highlight the influence of subclinical hearing deficits on cochlear tuning estimates and suggest that humans with optimal cochlear health may possess even sharper biological frequency selectivity than previously reported.

Indexed as

Auditory PerceptionCochleaOtoacoustic Emissions, SpontaneousAdultAuditory ThresholdFemaleHumansMaleMiddle AgedYoung AdultAuditory filtersCochlear tuningExtended high frequencyFrequency selectivityStimulus frequency otoacoustic emissionsSubclinical hearing loss

Identifiers

PMID41296209
PMCPMC12698895

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.